Kohwa Biotechnology: The subsidiary company jikong kenya hot virus RNA test kit has not yet applied for a medical device registration certificate.

On July 29, Kowa Biotech stated on the interactive platform that the Ebola virus RNA test kit of its holding subsidiary Xi'an Tianlong has not yet applied for a medical device registration certificate from the National Medical Products Administration. It can only be used as a research reagent for testing needs in customs, disease control, and other application scenarios. The company will closely monitor market demand, and will formulate product registration plans based on the actual business needs and development strategy of the company, actively seizing relevant business opportunities.